C
Costanza Rovida
Researcher at University of Konstanz
Publications - 47
Citations - 1933
Costanza Rovida is an academic researcher from University of Konstanz. The author has contributed to research in topics: Medicine & European union. The author has an hindex of 21, co-authored 42 publications receiving 1620 citations.
Papers
More filters
Journal ArticleDOI
Chemical regulators have overreached
Thomas Hartung,Costanza Rovida +1 more
TL;DR: The costs — both in animal lives and euros — of the European REACH legislation on chemical testing are escalating and Thomas Hartung and Costanza Rovida argue for a suspension of certain toxicity tests.
Journal ArticleDOI
A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing.
David A. Basketter,Harvey J. Clewell,Ian Kimber,Annamaria Rossi,Bas J. Blaauboer,Robert Burrier,Mardas Daneshian,Chantra Eskes,Alan M. Goldberg,Nina Hasiwa,Sebastian Hoffmann,Joanna Jaworska,Thomas B. Knudsen,Robert Landsiedel,Marcel Leist,Paul A. Locke,Gavin Maxwell,James M. McKim,Emily A. McVey,Gladys Ouedraogo,Grace Patlewicz,Olavi Pelkonen,Erwin Ludo Roggen,Costanza Rovida,Irmela Ruhdel,Michael Schwarz,Andreas Schepky,Greet Schoeters,Nigel Skinner,Kerstin Trentz,Marian Turner,Philippe Vanparys,James D. Yager,Joanne Zurlo,Thomas Hartung +34 more
TL;DR: In this paper, the authors present a roadmap for how to overcome the acknowledged scientific gaps for the full replacement of systemic toxicity testing using animals, which is a major concern for the current state of the art.
Journal ArticleDOI
Consensus report on the future of animal-free systemic toxicity testing.
Marcel Leist,Nina Hasiwa,Costanza Rovida,Mardas Daneshian,David A. Basketter,Ian Kimber,Harvey J. Clewell,Tilman Gocht,Alan M. Goldberg,Francois Busquet,Anna Rossi,Michael Schwarz,Martin L. Stephens,Rob Taalman,Thomas B. Knudsen,James M. McKim,Georgina Harris,David Pamies,Thomas Hartung +18 more
TL;DR: A focus on data quality, combined with increased attention to the scientific background of a test method, will be important drivers in the test development process, and quantitative information on all factors and key events will be fed into systems biology models that allow a probabilistic risk assessment with flexible adaptation to exposure scenarios and individual risk factors.
Journal ArticleDOI
Integrated Testing Strategies (ITS) for safety assessment.
Costanza Rovida,Nathalie Alépée,A.M. Api,David A. Basketter,Frédéric Y. Bois,Francesca Caloni,Emanuela Corsini,Mardas Daneshian,Chantra Eskes,Janine Ezendam,Horst W. Fuchs,Patrick Hayden,Christa Hegele-Hartung,Sebastian Hoffmann,Bruno Hubesch,Miriam N. Jacobs,Joanna Jaworska,Andre Kleensang,Nicole Kleinstreuer,J F Lalko,Robert Landsiedel,Frédéric Lebreux,Thomas Luechtefeld,Monica Locatelli,Annette Mehling,Andreas Natsch,Jonathan W. Pitchford,Donald Prater,Pilar Prieto,Andreas Schepky,Gerrit Schüürmann,Lena Smirnova,Colleen Toole,Erwin van Vliet,Dirk Weisensee,Thomas Hartung +35 more
TL;DR: The case of skin sensitization was taken as an example to understand how possible ITS can be constructed, optimized and validated, and will require embracing and developing new concepts such as adverse outcome pathways (AOP), advanced statistical learning algorithms and machine learning, mechanistic validation and "Good ITS Practices".
Journal ArticleDOI
Chemical reactivity measurement and the predicitve identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64
Frank Gerberick,Maja Aleksic,David A. Basketter,Silvia Casati,Ann-Therese Karlberg,Petra S. Kern,Ian Kimber,Jean Pierre Lepoittevin,Andreas Natsch,Jean Marc Ovigne,Costanza Rovida,Hitoshi Sakaguchi,Terry W Schultz +12 more
TL;DR: A number of recommendations listed at the end of the report are intended to promote the progress of relevant and reliable methods toward prevalidation and validation.